Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ellen L. Weisberg, Ph.D.

Concepts (401)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ellen Weisberg's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ellen Weisberg has written about over time.
Piperazines, 19 publications between 2001 and 2015, average publication date April 2006. Fusion Proteins, bcr-abl, 16 publications between 2000 and 2014, average publication date July 2006. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 14 publications between 1997 and 2021, average publication date October 2006. Protein-Tyrosine Kinases, 10 publications between 1997 and 2017, average publication date January 2007. Pyrimidines, 26 publications between 2000 and 2019, average publication date December 2007. Receptor, Platelet-Derived Growth Factor alpha, 4 publications between 2003 and 2012, average publication date March 2008. Drug Resistance, Neoplasm, 22 publications between 2001 and 2019, average publication date December 2008. Antineoplastic Agents, 34 publications between 1996 and 2022, average publication date April 2011. Staurosporine, 15 publications between 2002 and 2020, average publication date June 2011. Mutant Proteins, 4 publications between 2007 and 2019, average publication date June 2011. Leukemia, Myeloid, 5 publications between 2003 and 2020, average publication date December 2011. fms-Like Tyrosine Kinase 3, 25 publications between 2002 and 2021, average publication date March 2013. Protein Kinase Inhibitors, 33 publications between 2006 and 2020, average publication date June 2014. Leukemia, Myeloid, Acute, 24 publications between 2002 and 2022, average publication date July 2014. Phenylurea Compounds, 5 publications between 2012 and 2020, average publication date March 2016. Small Molecule Libraries, 4 publications between 2014 and 2021, average publication date April 2017. Proto-Oncogene Proteins c-cbl, 2 publications between 2019 and 2020, average publication date October 2019. Antiviral Agents, 3 publications between 2020 and 2022, average publication date April 2021. Drug Repositioning, 2 publications between 2020 and 2022, average publication date September 2021.

To see the data from this visualization as text, click here.
Weisberg's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (401)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.